The Kobeissi Letter drew attention to a significant spike in cryptocurrency card deposits, connecting the jump to growing stablecoin adoption.
Freedom Broker analyst Ilya Zubkov initiates coverage on Arcturus Therapeutics (NASDAQ:ARCT) with a Buy rating and announces Price Target of $27.
FedEx's Q4 EPS beat couldnât offset margin pressure and 2026 guidance doubts. Click to read more about the FDX stock.
Telefônica Brasil VIV faces minimal threat from Starlink, as customer overlap is limited to remote regions, not urban strongholds. Learn why VIV stoc...
The robotics industry is experiencing a transformation driven by advancements in artificial intelligence, automation, and machine learning.
China Renaissance analyst Ella Ji downgrades Trip.com Group (NASDAQ:TCOM) from Buy to Hold and announces $42 price target.
IREN joins Nasdaq-100/Russell, boosting institutional ownership; with AI capacity fully contracted, focus shifts to execution and revenue. Click to kn...
Jefferies analyst Lloyd Byrne maintains EOG Resources (NYSE:EOG) with a Buy and raises the price target from $170 to $175.
Procter & Gamble stock remains a Hold amid premium valuation and uneven returns vs. the S&P 500. Click here to read in detail about PG.
Canaccord Genuity analyst Kingsley Crane initiates coverage on Infleqtion (NYSE:INFQ) with a Buy rating and announces Price Target of $22.
PAR Technology Corporation is evolving into a comprehensive operating platform for restaurants and convenience stores. Read why PAR stock is a Hold.
Surgepays Inc (NASDAQ: SURG) rose in pre-market trading after amending agreement with wireless network provider, shares jumped 59% to $0.66.
Big Tech's mega-cap leaders suffered their worst month in years this June as investors fled the AI-spending trade and capital quietly rotates elsewher...
Perpetual futures contracts are complicated—and are often used with extreme leverage. You’re right to be wary.
AMD increased Su’s base salary from $1.32 million to $1.38 million.
Stryker looks undervalued after a cyber incident, with 32 years of dividend hikes, strong cash flow and M&A growth. Learn more on SYK stock here.
Barclays analyst Guy Hardwick maintains TD Synnex (NYSE:SNX) with a Equal-Weight and raises the price target from $237 to $278.
Loading...